Finance

Elliott rebuilds stake in SoftBank and pushes for $15 billion buyback, FT reports

Elliott rebuilds stake in SoftBank and pushes for $15 billion buyback, FT reports https://i-invdn-com.investing.com/news/LYNXNPEB9M0BY_L.jpg Source link Reuters

Modi’s smaller mandate to slow India’s fiscal tightening, Moody’s says By Reuters

By Siddhi Nayak MUMBAI (Reuters) - The narrower margin of victory for Indian Prime Minister Narendra Modi's alliance in elections will forestall...

Australia drops court action against Musk’s X over church stabbing posts By Reuters

By Renju Jose SYDNEY (Reuters) - Australia's cyber safety regulator on Wednesday decided to drop a legal challenge against Elon Musk-owned X...

sanjiv bhasin stocks: Sanjiv Bhasin’s top stock picks post yesterday’s market bloodbath

"The excesses were created on Monday because of the exit poll getting it all wrong and people leveraging in PSUs and so on...

Bank of Japan to reduce bond buybacks in June meeting- UBS By Investing.com

Investing.com-- The Bank of Japan is widely expected to keep interest rates unchanged when it meets later in June, but is likely to...

US Southwest expected to roast with pre-summer heat wave By Reuters

By Steve Gorman and Brendan O'Brien LOS ANGELES (Reuters) -Millions of Americans from the Gulf Coast of Texas to California's San Francisco...

market: Should market worry about whether policy continuity is here to stay or not? Swaminathan Aiyar explains

"I would say that policy continuity is guaranteed. The thing that is difficult always is making a U-turn or making a sharp left...

SEALSQ, WISeKey and The Hashgraph Association Join Forces to Bring Secure IoT and DePIN solutions to Saudi Arabia By Investing.com

Geneva, Switzerland / Riyadh, Saudi Arabia - June 5, 2024 “ SEALSQ Corp ("SEALSQ" or "Company") (NASDAQ: LAES), a company that focuses on...

Report on the Combined General Meeting of June 4, 2024 By Investing.com

PARIS--(BUSINESS WIRE)--Regulatory News: Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor...

Latest articles

spot_imgspot_img